Immunity over inability: The spontaneous regression of cancer

Journal of Natural Science, Biology and Medicine

Volumn 2, Issue 1, 2011, Pages 43-49

  Jessy, Thomas ^a  

^a Dr Syamala Reddy Dental College Hospital   (India)

Author keywords

Acute infections; Cancer; Coley's toxins; Fever; Immunostimulation; Spontaneous regression

Indexed keywords

EID: 84878802844     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.82318     Document Type: Review

References (49)

1. Hoption Cann SA, van Netten JP, van Netten C, Glover DW. Spontaneous regression: A hidden treasure buried in time. Med Hypotheses 2002;58:115-9.
2. Cancer. gov. United States: National cancer institute. Dictionary of cancer terms. Available from: http://www.cancer.gov/ dictionary/?CdrID=46039. [Last accessed on 2010 Sep, cited 2010 Oct].
3. Le Dran HF. Traite des operations de chirurgie. Paris: C. Osmont; 1742.
4. Everson TC. Spontaneous regression of cancer. Prog Clin Cancer 1967;3:79-95.
5. Everson T, Cole W. Spontaneous Regression of Cancer. Philadelphia, PA: WB Saunders; 1968.
6. Pubmed.gov. United States: Search of PubMed database, web site of the National Institutes of Health, returned 302 articles published in 2010 including the terms "cancer" and "spontaneous regression." Available from: http://www.ncbi.nlm.nih.gov/pubmed. [Last accessed on 2010 Dec 30 and cited 2010 Jan 07].
7. Pakhmode VK. Understanding the possible mechanisms of spontaneous regression of oral cancer. J oral and maxillofac pathol 2007;11:2-4.
8. Who.int> W.H.O. cancer estimates 2003. Available from: http://www. who.int/mediacentre/news/releases/pr27/en. [Last accessed on 2010 Nov 30 and cited 2010 Dec 10].
9. Savarrio L, Gibson J, Dunlop DJ, O'Rourke N, Fitzsimons EJ. Spontaneous regression of an anaplastic large cell lymphoma in the oral cavity: First reported case and review of literature. Oral Oncol 1999;35:609-13.
10. Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: A place in history or in the future? Postgraduate Med J 2003;79:672-80.
11. Rohdenburg GL. Fluctuations in the growth energy of tumors in man, with especial reference to spontaneous recession. J Cancer Res 1918;3:193-225.
12. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas, with a report of ten original cases. Am J Med Sci 1893;105:487-511.
13. Coley WB. Contribution to the knowledge of sarcoma. Ann Surg 1891;14:199-220.
14. Coley WB. Treatment of inoperable malignant tumors with toxins of erysipelas and the bacillus prodigiosus. Trans Am Surg Assn 1894;12:183-212.
15. Richardson MA, Ramirez T, Russell NC, Moye LA. Coley toxins immunotherapy: A retrospective review. Altern Ther Health med 1999;5:42-7.
16. Nauts HC. The benefi cial eff ects of bacterial infections on host resistance to cancer: End results in 449 cases. 2nd ed. Monograph no. 8. New York: Cancer research institute; 1980.
17. Nauts HC, Fowler GA, Bogatko FH. A review of the infl uence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man. Acta Med Scand Suppl 1953;276:1-103.
18. Nauts HC. Immunotherapy of cancer by microbial products. In Mizuno D, editor. Host defense against cancer and its potentiation. Baltimorey, MD: Universit Park Press; 1975. p. 337-15
19. Beebe SP, Tracy M. The treatment of experimental tumors with bacterial toxins. JAMA 1907;49:1493-8.
20. Coley WB. Late results of treatment of inoperable sarcoma by mixed toxins of erysipelas and bacillus prodigiosus. Am J Med Sci 1906;131:375-440.
21. Ebbel B. The papyrus ebers: The greatest Egyptian medical documents. London: Oxford University Press; 1937.
22. Nauts HC, Pelner L, Fowler GA, sarcoma of the soft tissues other than lymphosarcoma, treated by toxin therapy: New York: Cancer Research Institute; 1969.
23. Nauts HC, Fowler GA, Bogatko FH. A review of the infl uence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man. Acta Med Scand Suppl 1953;276:28-30.
24. Coley WB. Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and Bacillus prodigiosus. Am J Med Sci 1906;131:398-9.
25. Nauts HC. Bacteria and cancer- antagonisms and benefi ts. Cancer Surv 1989;8:720.
26. MacAdam DH, Spontaneous Regression: Cancer and the Immune System, Xlibris: Philadelphia 2003. Available from: http://www. mbvax.com/pdf/book- excerpt.pdf. [Last accessed on 2009 June, Cited 2009 Sep].
27. Cancer.org. United States. American Cancer Society appeal for funding. Website of the Illinois State and University Employees Combined Appeal. Available from: http://www.secaillinois.org/acs. hlm. [Last Accessed on 2002 Dec 17].
28. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics, 2001. CA Cancer J Clin 2001;51:15-36.
29. Cancer.gov. United States: National cancer institute. Dictionary of cancer terms. Available from: http://www.cancer.gov/ dictionary/?CdrID=597152. [Last accessed on 2010 Oct 30; cited 2010 Nov 29].
30. Thomas Allen and Son, Webster's Ninth New Collegiate Dictionary. Ontario: Markham; 1989. p. 316.
31. Epstein JB. Oral cancer. Greenberg, Glick, editors. Burkets textbook of oral medicine. 10th ed. Elseiver India: BC Decker Inc; 2003. p. 194-227.
32. Seer.cancer.gov. United States: National Cancer Institute. Cancer statistics Table I-2, National Cancer Institute website. Available from: http://www.seer.cancer.gov. [Last accessed on 2010 Oct 30: Cited 2010 Nov 29.]
33. van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coff ey JC, van Egmond M. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann surg 2009;249:727-34.
34. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003;133:547-55.
35. Peen J. Cancer in immunosuppressed patients. Transplant Proc 1984;16:492-4.
36. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities. Arch Intern Med 2002;162:1985-93.
37. Smithers DW. Spontaneous Regression of Tumors. Clin Radiol 1962;13:132-7.
38. Fauvet J; Campagne J; Chavy A; Piet G Cures, Regressions and Spontaneous Remissions of Cancer. La Revue du Praticien 1960;10:2349-84.
39. Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, et al. Role of HER2 in wound-induced breast carcinoma proliferation. Lancet 2003;362:527-33.
40. Kleef R, Jonas WB, Knogler W, Stenzinger W. Review of fever, cancer incidence and spontaneous remissions. Neuroimmunomodulation 2001;9:55-64.
41. Abel U, Becker N, Angerer R, Frentzel-Beyme R, Kaufmann M, Schlag P, et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991;117:339.
42. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
43. Hoption Cann SA, van Netten JP, van Netten C. Acute infections as a means of cancer prevention: Opposing eff ects to chronic infections? Cancer Detect Prev 2006;30:83-93.
44. Power D. The local distribution of cancer and cancer houses. Practitioner 1899;62:418-29;
45. quoted in Graner J. History of infectious disease oncology, from Galen to Rous. Infectious Causes of Cancer. Goedert, James J, editor. Totowa, New Jersey: Humana Press; 2000. p. 16.
46. Wang R. Regulatory T cells and innate immune regulation in tumor immunity. Springer Semin Immunopathol 2006;28:17-23.
47. Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother 2001;50:391-6.
48. Quesnay F. Traite de la gangarene. Paris d houry;1749:313.
49. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168:2311-16, 2302-03.